Back Stocks profile

Stock analysis tool for investors

Global Longlife Hospital and Research Ltd.

NSE: 16550649 | BSE:543520

₹31.00 -1.00 (-3.12%) 1D

Diversified Consumer Services

Open an Account with Bigul in 5 minutes

Performance

Today’s low

30.30

Today’s High

31.10

52W low

27.00

52W High

61.70

Open Price

30.30

Prev. Close

31.8800

Volume

7000.00

Value

217000.00

Fundamentals

Market Cap Cr

32.60

Price to Earnings

0.00

Price to Book Value

1.30

Dividend Yield

0.00

PE to Growth

0.00

Op Revenue TTM Cr

0.00

Net Profit TTM Cr

0.00

Cash From Operating Activity Cr

-5.07

Return on Equity %

-8.43

EMA & SMA

Bullish Moving Averages

0

Bearish Moving Averages

16

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

03 Jul, 2024

100

Week

100

Month

89.9

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

30.78

PIVOT

First Resistance

31.28

Second Resistance

31.57

Third Resistance

32.07

First Support

30.49

Second Support

29.99

Third Support

29.70

Relative Strength Index

39.12

Money Flow Index

22.63

MACD

-1.14

MACD Signal

-1.27

Average True Range

2.27

Average Directional Index

27.48

Rate of Change (21)

-1.24

Rate of Change (125)

-29.55

Commodity Channel Index

-127.6

Williams %R

-60

BETA

1 Month

-0.57

3 Month

-0.38

1 Year

-0.14

3 Year

PRICE CHANGE ANALYSIS

-8.5%

1 Week

Low

High

30.27

33.8

-5.2%

1 Month

Low

High

27

37

-26.19%

3 Months

Low

High

27

45

-42.28%

6 Months

Low

High

27

61.7

-21.18%

1 Year

Low

High

27

61.7

Bigul
14 May 2024

Global Longlife Hospital and Research Ltd - 543520 - Shareholder Meeting / Postal Ballot-Outcome of EGM

Summary of the proceedings of the Extra-ordinary General Meeting (EGM) No. 1 (2024/25) of the Company held on Tuesday, May 14, 2024.
Bigul
12 May 2024

Global Longlife Hospital and Research Ltd - 543520 - Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results Along With The Audit Report For The Half Year And Year Ended On March 31, 2024

Global Longlife Hospital And Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2024 ,inter alia, to consider and approve Audited Financial Results along with the Audit Report for the Half Year and Year ended on March 31, 2024.
Bigul
29 Apr 2024

Global Longlife Hospital and Research Ltd - 543520 - Submission Of Certificate Under Regulation 40(9) Read With Regulation 40(10) Of The SEBI (LODR) Regulations, 2015

Certificate under Regulation 40(9) read with Regulation 40(10) of the SEBI (LODR) Regulations, 2015
Bigul
17 Apr 2024

Global Longlife Hospital and Research Ltd - 543520 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Clarification for non applicability of Regulation 24(A) of SEBI (LODR) Regulations, 2015 for the year ended March 31, 2024
Bigul
17 Apr 2024

Global Longlife Hospital and Research Ltd - 543520 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2024
See all News

FAQs

The latest market price of Global Longlife Hospital and Research Ltd. on NSE was Rs. 31.00 as of today.

The opening share price of Global Longlife Hospital and Research Ltd. was Rs. 30.30 as of today.

The 52-week high share price of Global Longlife Hospital and Research Ltd. was Rs. 61.70.

The 52 week low share price of Global Longlife Hospital and Research Ltd. was Rs. 27.00.

Global Longlife Hospital and Research Ltd. has a market cap of Rs. 32.60 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Global Longlife Hospital and Research Ltd. is 0.00. Please refer to the Fundamentals section for further details.

The operating revenue for Global Longlife Hospital and Research Ltd. in the last FY was Rs.  0.00 crore. Please refer to the Financials section for further details.

The Net Profit for Global Longlife Hospital and Research Ltd. in the last FY was Rs. 0.00 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Global Longlife Hospital and Research Ltd..

Close

Let's Open Free Demat Account